-- Amendment revised royalty structure from low-to-mid-single digits to 1% on global net sales of Rhythm MC4R agonists, including setmelanotide, bivamelagon and RM-718 -- -- Rhythm secures $750 ...

Spero Therapeutics is a clinical-stage biopharmaceutical company focused on advancing next-generation medicines for patients with serious immune-mediated diseases. The company’s lead program, SP001, ...

For the third quarter, worldwide revenue of $142.4 million advanced 3%, primarily driven by growth in Pain Treatments. Net income attributable to Bioventus Inc. was $6.0 million, compared to $3.2 ...

Conference call and webcast to be held at 4:30 p.m. ET ...

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral ...

- Keith A. Goldan to retire as CFO and remain with the Company through year-end to support the transition - ...

The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events ...

An audio webcast of the discussions will be available online at the OrthoPediatrics’ investor relations website, http://ir.orthopediatrics.com. Additionally, a replay will be available after the ...

Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for ...

Dr. Shahidi brings extensive drug development experience, regulatory success, and transformative operational expertise to the Board ...

In October, CRISPR Therapeutics announced the appointment of A.J. Silver, the Company’s Senior Vice President of Finance, as Chief Financial Officer, effective October 19, 2026, succeeding Raju Prasad ...

Guggenheim 3rd Annual Healthcare Innovation Conference: Marino Garcia, CEO, will participate in a fireside chat on Monday, November 9, 2026, at 11:00 a.m. ET. Marino Garcia and Ryan Savitz, EVP, CFO & ...